Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 10, 2019

SELL
$5.32 - $7.18 $2,660 - $3,590
-500 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$4.95 - $10.5 $4,950 - $10,500
-1,000 Reduced 66.67%
500 $3,000
Q3 2018

Nov 14, 2018

SELL
$9.2 - $11.5 $4,600 - $5,750
-500 Reduced 25.0%
1,500 $16,000
Q2 2018

Aug 03, 2018

SELL
$7.8 - $11.1 $39,000 - $55,500
-5,000 Reduced 71.43%
2,000 $22,000
Q4 2017

Feb 02, 2018

BUY
$5.95 - $8.35 $41,650 - $58,450
7,000
7,000 $57,000

About CHEMBIO DIAGNOSTICS, INC.


  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Sea Crest Wealth Management, LLC Portfolio

Follow Sea Crest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.